Scoop has an Ethical Paywall
Licence needed for work use Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Pseudoephedrine classification OK for pharmacists

Media Release
8 October 2009

Re-classification of pseudoephedrine is business as usual for pharmacists

Following today’s announcement that pseudoephedrine will be reclassified as a prescription-only medicine, the Pharmacy Guild of New Zealand shares the Prime Minister’s commitment to the menace of “P” and understands why he has taken these steps. The Guild says that products containing pseudoephedrine are only a small part of what community pharmacists do and that they will continue to provide good healthy advice to patients and exercise vigilance over a wide range of drugs.

“We hope patients will appreciate that pharmacists will no longer be able to provide pseudoephedrine products without a prescription from their doctor,” says Pharmacy Guild Chief Executive, Annabel Young. “We expect that these changes will create a lot of work for pharmacists.

“The government’s decision to make pseudoephedrine prescription-only has not changed its status as an unsubsidised drug. For that reason pharmacists will not be required to stock and/or supply pseudoephedrine even if the patient has a prescription from a doctor.

“The sales of pseudoephedrine have been declining for some time and it is unclear how the market will react to these changes,” says Ms Young. “Some patients have reported that alternative products containing phenylephrine are not as effective a decongestant as pseudoephedrine but there are mixed views on this.”

ENDS

Advertisement - scroll to continue reading

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.